+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alizapride Market by Route Of Administration (Intramuscular, Intravenous, Oral), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Therapeutic Indication - Global Forecast 2025-2030- Product Image
Alizapride Market by Route Of Administration (Intramuscular, Intravenous, Oral), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Therapeutic Indication - Global Forecast 2025-2030- Product Image
Sale

Alizapride Market by Route Of Administration (Intramuscular, Intravenous, Oral), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End User, Therapeutic Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6014922
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global alizapride market is experiencing significant transformation, driven by advances in clinical practice, evolving regulatory guidance, and dynamic supply chain conditions. Senior industry leaders require targeted insights to navigate this increasingly complex landscape and unlock new growth opportunities.

Market Snapshot: Alizapride Market Growth and Outlook

The Alizapride Market grew from USD 7.28 billion in 2024 to USD 7.84 billion in 2025. It is expected to continue growing at a CAGR of 7.48%, reaching USD 11.23 billion by 2030. Key growth drivers include its inclusion in antiemetic protocols for chemotherapy and surgical patients, a favorable safety profile recognized in clinical settings, and increasing interest in multi-modal and personalized therapy approaches.

Scope & Segmentation: Strategic Market Dimensions

This comprehensive analysis provides critical insights into key segments and global regions shaping alizapride utilization. Understanding the nuanced applications and delivery formats is essential for strategic planning:

  • Route of Administration: Intramuscular (multi-dose, single-dose), intravenous (bolus infusion, continuous infusion), and oral (solution, tablet) options target diverse patient needs and clinical settings.
  • Distribution Channel: Hospital pharmacies (private, public), online pharmacies (direct to patient, third-party marketplaces), and retail pharmacies (chain, independent) structure product flow and impact geographical reach.
  • End User Environments: Clinics (general, oncology), home care (nurse-administered, self-administered), and hospitals (private, public) employ tailored approaches around treatment protocols and patient preferences.
  • Therapeutic Indication: Chemotherapy-induced nausea (adult, pediatric), postoperative nausea (day surgery, inpatient surgery), and pregnancy-related nausea (hyperemesis gravidarum, morning sickness) inform product selection and care pathways.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, and others), and Asia-Pacific (China, India, Japan, Australia, and more) provide distinct adoption trends and supply dynamics.
  • Key Companies: Leading participants include Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals PLC, Viatris Inc., Cipla Limited, and Aspen Pharmacare Holdings Limited.

Key Takeaways: Strategic Insights for Decision Makers

  • Alizapride’s expanding role in antiemetic protocols supports consistent integration across oncology, perioperative, and outpatient care settings. Enhanced clinical adoption is linked to favorable response rates and managed risk profiles in vulnerable patient groups.
  • Manufacturers are refining formulation portfolios, investing in novel delivery systems such as controlled infusion pumps and extended-release mechanisms to increase both convenience and adherence.
  • Competitive dynamics reflect a blend of multinational R&D-driven innovation with cost-focused generic offerings, ensuring broad market participation and differentiation in both mature and emerging regions.
  • Collaborative partnerships—between brand developers, contract manufacturers, and digital health providers—accelerate pipeline advancement and address diverse market access requirements.
  • Personalized medicine initiatives are spurring development of precision dosing algorithms and biomarker-driven treatment protocols, enabling improved efficacy with minimized side effects for complex patient cohorts.

Tariff Impact: Navigating US Market Challenges

The 2025 United States tariffs on pharmaceutical excipients and packaging materials have introduced cost pressures and logistical hurdles for alizapride manufacturers. To mitigate these headwinds, supply chain participants are diversifying sourcing strategies and exploring alternative trade routes, ensuring continued product availability for both hospital and outpatient distributors. Pricing strategies are being recalibrated to address fluctuating landed costs and changing inventory planning requirements.

Methodology & Data Sources

This report applies a robust methodology, combining primary data from stakeholder interviews and expert consultations with secondary research from peer-reviewed publications, policy directives, and industry benchmarks. Scenario-based modeling and thematic analysis inform a reliable market perspective.

Why This Report Matters for Senior Decision-Makers

  • Empowers executives with actionable intelligence on evolving clinical, regulatory, and supply chain trends impacting the alizapride market.
  • Guides strategy development for market entry, portfolio optimization, and partnership selection across diverse geographies and distribution models.
  • Supports informed investment, procurement, and operational planning by highlighting risk mitigation and innovation pathways.

Conclusion: Steering Growth and Innovation

This report delivers a clear, segmented view of the alizapride market, aligning commercial priorities with clinical best practices and regional realities. Readers gain the strategic context needed to drive sustainable growth and operational excellence as antiemetic therapies continue to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing off-label use of Alizapride in chemotherapy-induced nausea management driven by updated supportive care guidelines
5.2. Expansion of generic Alizapride availability leading to intensified price competition in key emerging markets
5.3. Shift toward intravenous Alizapride formulations for hospital-based postoperative nausea protocols to enhance patient recovery
5.4. Growing interest in combination therapy of Alizapride with serotonin antagonists to improve control in refractory emesis cases
5.5. Regulatory approval processes for Alizapride generics accelerating in Asia-Pacific markets amid rising antiemetic demand
5.6. Rising investment in clinical trials assessing Alizapride efficacy in gastroparesis-related nausea symptoms in diabetic populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Alizapride Market, by Route Of Administration
8.1. Introduction
8.2. Intramuscular
8.2.1. Multi Dose
8.2.2. Single Dose
8.3. Intravenous
8.3.1. Bolus Infusion
8.3.2. Continuous Infusion
8.4. Oral
8.4.1. Oral Solution
8.4.2. Tablet
9. Alizapride Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.2.1. Private Hospitals
9.2.2. Public Hospitals
9.3. Online Pharmacies
9.3.1. Direct To Patient
9.3.2. Third Party Marketplaces
9.4. Retail Pharmacies
9.4.1. Chain Pharmacies
9.4.2. Independent Pharmacies
10. Alizapride Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General
10.2.2. Oncology
10.3. Home Care
10.3.1. Nurse Administered
10.3.2. Self Administered
10.4. Hospitals
10.4.1. Private
10.4.2. Public
11. Alizapride Market, by Therapeutic Indication
11.1. Introduction
11.2. Chemotherapy Induced Nausea
11.2.1. Adult
11.2.2. Pediatric
11.3. Postoperative Nausea
11.3.1. Day Surgery
11.3.2. Inpatient Surgery
11.4. Pregnancy Related Nausea
11.4.1. Hyperemesis Gravidarum
11.4.2. Morning Sickness
12. Americas Alizapride Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Alizapride Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Alizapride Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sandoz International GmbH
15.3.2. Teva Pharmaceutical Industries Ltd.
15.3.3. Sun Pharmaceutical Industries Limited
15.3.4. Dr. Reddy's Laboratories Limited
15.3.5. Hikma Pharmaceuticals PLC
15.3.6. Viatris Inc.
15.3.7. Cipla Limited
15.3.8. Aspen Pharmacare Holdings Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ALIZAPRIDE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALIZAPRIDE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALIZAPRIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALIZAPRIDE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALIZAPRIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ALIZAPRIDE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES ALIZAPRIDE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ALIZAPRIDE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. ALIZAPRIDE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. ALIZAPRIDE MARKET: RESEARCHAI
FIGURE 24. ALIZAPRIDE MARKET: RESEARCHSTATISTICS
FIGURE 25. ALIZAPRIDE MARKET: RESEARCHCONTACTS
FIGURE 26. ALIZAPRIDE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALIZAPRIDE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALIZAPRIDE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALIZAPRIDE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALIZAPRIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALIZAPRIDE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALIZAPRIDE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALIZAPRIDE MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALIZAPRIDE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALIZAPRIDE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALIZAPRIDE MARKET SIZE, BY BOLUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALIZAPRIDE MARKET SIZE, BY BOLUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALIZAPRIDE MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALIZAPRIDE MARKET SIZE, BY CONTINUOUS INFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALIZAPRIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALIZAPRIDE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALIZAPRIDE MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALIZAPRIDE MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALIZAPRIDE MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALIZAPRIDE MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALIZAPRIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALIZAPRIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALIZAPRIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALIZAPRIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ALIZAPRIDE MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ALIZAPRIDE MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ALIZAPRIDE MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ALIZAPRIDE MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ALIZAPRIDE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ALIZAPRIDE MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ALIZAPRIDE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ALIZAPRIDE MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ALIZAPRIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ALIZAPRIDE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ALIZAPRIDE MARKET SIZE, BY GENERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ALIZAPRIDE MARKET SIZE, BY GENERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ALIZAPRIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ALIZAPRIDE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ALIZAPRIDE MARKET SIZE, BY NURSE ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ALIZAPRIDE MARKET SIZE, BY NURSE ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ALIZAPRIDE MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ALIZAPRIDE MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ALIZAPRIDE MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ALIZAPRIDE MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ALIZAPRIDE MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ALIZAPRIDE MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ALIZAPRIDE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ALIZAPRIDE MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ALIZAPRIDE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ALIZAPRIDE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ALIZAPRIDE MARKET SIZE, BY DAY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ALIZAPRIDE MARKET SIZE, BY DAY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ALIZAPRIDE MARKET SIZE, BY INPATIENT SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ALIZAPRIDE MARKET SIZE, BY INPATIENT SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ALIZAPRIDE MARKET SIZE, BY HYPEREMESIS GRAVIDARUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ALIZAPRIDE MARKET SIZE, BY HYPEREMESIS GRAVIDARUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ALIZAPRIDE MARKET SIZE, BY MORNING SICKNESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ALIZAPRIDE MARKET SIZE, BY MORNING SICKNESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES ALIZAPRIDE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES ALIZAPRIDE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 181. CANADA ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 184. CANADA ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 185. CANADA ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 186. CANADA ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 187. CANADA ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 188. CANADA ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 189. CANADA ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. CANADA ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. CANADA ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 192. CANADA ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 193. CANADA ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 194. CANADA ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 195. CANADA ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 196. CANADA ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 197. CANADA ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. CANADA ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. CANADA ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. CANADA ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. CANADA ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 202. CANADA ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 203. CANADA ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. CANADA ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. CANADA ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 206. CANADA ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 207. CANADA ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 208. CANADA ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 209. CANADA ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 210. CANADA ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 211. CANADA ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 212. CANADA ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 213. MEXICO ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. MEXICO ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. MEXICO ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 216. MEXICO ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 217. MEXICO ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 220. MEXICO ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 221. MEXICO ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. MEXICO ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. MEXICO ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. MEXICO ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. MEXICO ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 236. MEXICO ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 237. MEXICO ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 238. MEXICO ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 239. MEXICO ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 240. MEXICO ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 241. MEXICO ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 242. MEXICO ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 243. MEXICO ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 244. MEXICO ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 328. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 329. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 330. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 331. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 332. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 333. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2024 (USD MILLION)
TABLE 334. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY THERAPEUTIC INDICATION, 2025-2030 (USD MILLION)
TABLE 335. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2018-2024 (USD MILLION)
TABLE 336. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY CHEMOTHERAPY INDUCED NAUSEA, 2025-2030 (USD MILLION)
TABLE 337. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2018-2024 (USD MILLION)
TABLE 338. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY POSTOPERATIVE NAUSEA, 2025-2030 (USD MILLION)
TABLE 339. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2018-2024 (USD MILLION)
TABLE 340. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY PREGNANCY RELATED NAUSEA, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA ALIZAPRIDE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 343. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 344. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 345. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2018-2024 (USD MILLION)
TABLE 346. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY INTRAMUSCULAR, 2025-2030 (USD MILLION)
TABLE 347. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 348. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 349. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 350. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 351. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 354. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 355. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 356. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 357. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 358. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 359. UNITED KINGDOM ALIZAPRIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 360. UNITED

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Alizapride market report include:
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Limited
  • Hikma Pharmaceuticals PLC
  • Viatris Inc.
  • Cipla Limited
  • Aspen Pharmacare Holdings Limited

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.23 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Alizapride (CAS 59338-93-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Alizapride (CAS 59338-93-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Domperidone API Market by Indication (Gastroesophageal Reflux Disease, Gastroparesis, Nausea And Vomiting), Dosage Form (Capsules, Suspensions, Tablets), Route Of Administration, End User, Distribution Channel, Manufacturer Type - Global Forecast 2025-2030 - Product Image

Domperidone API Market by Indication (Gastroesophageal Reflux Disease, Gastroparesis, Nausea And Vomiting), Dosage Form (Capsules, Suspensions, Tablets), Route Of Administration, End User, Distribution Channel, Manufacturer Type - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Palonosetron HCl API Market by Application, Route Of Administration, End User, Dosage Form, Distribution Channel, Strength - Global Forecast 2025-2030 - Product Image

Palonosetron HCl API Market by Application, Route Of Administration, End User, Dosage Form, Distribution Channel, Strength - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report 2025 - Product Image

Chemotherapy-Induced Nausea and Vomiting (CINV) Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Chemotherapy Induced Nausea Vomiting Market Report and Forecast 2025-2034 - Product Image

Chemotherapy Induced Nausea Vomiting Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From

About the Alizapride Market

Alizapride is a type of gastrointestinal drug used to treat symptoms of gastrointestinal disorders such as nausea, vomiting, and abdominal pain. It is a dopamine antagonist, meaning it blocks the action of dopamine in the brain, which can help reduce nausea and vomiting. Alizapride is available in both oral and injectable forms, and is often used in combination with other medications to treat more severe symptoms. It is also used to treat irritable bowel syndrome and other functional gastrointestinal disorders. Alizapride is a widely used drug in the gastrointestinal market, and is available from many pharmaceutical companies. Some of the companies that produce alizapride include Sanofi, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.